Back to Investors
Oxford Science Enterprises

Oxford Science Enterprises

Venture Capital

Oxford Science Enterprises is an independent investment company that backs science and technology businesses emerging from the University of Oxford.

Portfolio

13

companies

AUM

£1000M

under management


Portfolio companies

Kneu Health

Kneu Health

A precision neurology platform for tracking Parkinson and dementia via smartphones.

NH

Neu Health

Neu Health builds a digital care platform for neurology patients.

N

Natcap

Natcap delivers nature intelligence technology that helps businesses measure and report ecological risks.

PQShield

PQShield

PQShield builds quantum-resistant cryptographic solutions for the global technology supply chain.

Oxford Quantum Circuits

Oxford Quantum Circuits

Oxford Quantum Circuits builds enterprise-ready quantum computing platforms.

Navenio

Navenio

Navenio provides indoor location technology and task allocation software to improve healthcare workflow efficiency.

CD

Caristo Diagnostics

Caristo Diagnostics develops AI-assisted tools for cardiac and vascular disease diagnostics.

QM

Quantum Motion

Quantum Motion develops silicon-based quantum computing architectures compatible with standard semiconductor manufacturing.

Oxford Ionics

Oxford Ionics

Oxford Ionics builds high-performance quantum computers using trapped-ion technology.

BP

Brill Power

Brill Power develops intelligent battery management systems to improve energy storage and vehicle performance.

ORCA Computing

ORCA Computing

ORCA Computing develops full-stack photonic quantum computing systems.

mT

moa Technology

moa Technology develops sustainable herbicides and crop protection discovery platforms.

SL

Salience Labs

Salience Labs builds ultra high-speed multi-chip processors that combine photonics and electronics for artificial intelligence applications.


Team

MA

Matt Arnold

Principal

AZ

Alexis Zervoglos

Partner

MF

Martin Fiennes

Principal

WG

Will Goodlad

SH

Sam Harman

Investor Director

HR

Heather Roxborough

senior partner of Health Tech

ND

Nick Dixon-Clegg

Partner

SS

Schoppig Schoppig

Health Tech Investment Principal


Recent investments

Seed
£4.2M

The round was co-led by Oxford Science Enterprises and Cedars-Sinai to accelerate US expansion.

"We’ve spent the last two years proving that remote monitoring can transform neurological care. Clinicians are getting clearer insight without added workload, patients no longer face months of uncertainty between visits, and gain confidence that changes will be recognized rather than missed."
— Caroline Cake, co-founder and CEO
Seed
£1.6M

Cedars-Sinai and Oxford Science Enterprises backed the seed round to support expansion into the American market.

"The research produced at Oxford is of the highest caliber. An ongoing relationship with OSE will serve our patients and also strengthen the academic and clinical missions of Cedars-Sinai."
— Shlomo Melmed, executive vice president of Medicine & Health Sciences and dean of the Medical Faculty
Series A
£7.8M

The oversubscribed round saw backing from investors including André Hoffmann and Oxford Science Enterprises to expand environmental reporting tools.

"It has been truly exciting to see the level of investor interest in our company, particularly in a less-than-optimal fundraising environment globally,"
— Sebastian Leape, CEO
Series B
£29.0M

Addition led the Series B round with participation from Chevron Technology Ventures, Legal & General, Braavos Capital, and Oxford Science Enterprises.

"As we approach the culmination of the NIST project, we expect newly-ratified standards to help drive rapid adoption of PQC across the technology supply chain. Led by an industry-leading team with decades of experience, PQShield has quickly established itself as a leading authority in post-quantum cryptography for hardware and software. We are excited to see the business continue to build on its existing commercial success and further enhance its efforts in protecting our digital future."
— Todd Arfman
Series B
£78.8M

SBI Investment led the Series B round to support the international rollout of OQC quantum platforms.

"To solve the world's most pressing challenges – from climate change to accelerated drug discovery – we need to put quantum computers in the hands of humanity and at the fingertips of our most brilliant minds. We're proud to be pioneering enterprise ready quantum with our customers, partners and investors."
— Ilana Wisby, Chief Executive Officer
Series A
£5.0M

The funding round was led by Oxford Science Enterprises to support growth in the US and UK markets.

"We invest in companies with the potential to become leaders in their field, and that is why we’re proud to back the incredible team at Navenio on their latest fundraise. Navenio is revolutionising the way we create more efficient healthcare workplaces, through its proven technology powered platform for indoor mapping, and we are excited to continue supporting the team on the next stage of the company’s journey as they look to deliver its offering to a wider range of use cases and across new geographies."
— Heather Roxborough, senior partner of Health Tech
Series A
£13.0M

The financing round was led by Oxford Science Enterprises and will support market expansion in the UK, EU, and United States.

"We are thrilled that five successful institutional investors participated in the financing round which validates the vast clinical and business potential of Caristo’s innovations"
— Oran Muduroglu, Board Chairman
£42.0M

The oversubscribed round was led by Bosch Ventures with backing from Porsche SE and British Patient Capital.

"The support of leading technology investors enables us to realise our vision of a quantum computer built using standard foundry processes. This support, along with the continuing UK national quantum programme and European initiatives, provides a step-change in our capabilities. We have assembled a world leading team and with the funding and support in place, we are ready to scale and deliver on our vision."
— James Palles-Dimmock, CEO
Series A
£30.0M

The Series A round was led by Oxford Science Enterprises and Braavos Investment Advisers to support company expansion.

"Through its unique approach, developed by some of the world’s best minds in the quantum space, Oxford Ionics is laying the foundations to finally make quantum computing a scalable, integrable and viable option. Building on more than a decade at the forefront of this sector, Chris, Tom and the team have been able to demonstrate, time and again, that their work in the lab can, and will, extend to the real world and we’re thrilled to be joining them on this journey."
— Will Goodlad
Series A
£8.7M

The funding will support team growth and product development for energy storage and electric vehicles.

"As we grow our climate and clean energy platform, investing in Brill Power is an exciting move into energy storage technologies that are crucial to enable an increase of renewables on the power grid, electrification of transport, and to power our homes, businesses and key infrastructure. Through extended lifetimes, improved safety, and waste reduction, Brill Power’s work is setting a new standard for how to store and use clean power to accelerate progress to our net zero emissions goals."
— John Bromley, Managing Director, Clean Energy
Series A
£38.0M

The financing was co-led by Lansdowne Partners and The University of Tokyo Edge Capital Partners.

"Quantum computing promises to be the next frontier of innovation, and OQC, with its state-of-the-art Coaxmon technology, aims to integrate the forefront of modern physics into our everyday lives. UTEC is honoured to be part of OQC’s mission of making quantum technology accessible to all and will support OQC’s expansion into Asia-Pacific through collaborations with academia including the University of Tokyo, and partnerships with Japan’s leading financial and tech corporations."
— Lenny Chin, Principal
Series A
£12.5M

The Series A round was led by Octopus Ventures, Oxford Science Enterprises, Quantonation, and Verve Ventures.

"Light has a huge part to play in the future of quantum computing as an effective, scalable resource. Our mission is to put photonic systems in the hands of users today so that we deliver value in the short as well as long term,"
— Richard Murray, CEO
Series B
£35.0M

The financing round was co-led by Lansdowne Partners, Oxford Science Enterprises, and Parkwalk Advisors.

"Global agriculture needs a new Green Revolution if we are to feed the world sustainably. Being able to control weeds is critical to both yield and the cost of production in most crops and new herbicide modes of action are essential. It’s very exciting to see moa starting to play its part in this new revolution by advancing so far in such little time."
— Hadyn Parry, Chairman
Seed
£9.4M

The seed round was co-led by Cambridge Innovation Capital and Oxford Science Enterprises to accelerate the development of photonic artificial intelligence processors.

"Salience Labs brings together deep domain expertise in photonics, electronics and CMOS manufacture."
— Ian Lane, Partner
Series A
£14.8M

Addition led the Series A round to support product development, hiring and global expansion.

"Thanks to an industry-leading team, decades of combined experience and a best-in-class product offering, PQShield has quickly emerged as a front runner and true authority in post-quantum cryptography for hardware and software, a field with enormous market potential. PQShield is already helping to define the future of information security, and we are excited to support their ongoing growth."
— Lee Fixel
Series A
£9.5M

The Oxford Science Enterprises-led round will support US expansion and continued domestic growth in healthcare.

"I’m delighted our investors have again demonstrated their belief in the vast potential that Navenio can bring by ensuring ‘right person, right place, right time’. Artificial intelligence is one of many technologies making a real-world impact in the health sector, and this investment enables the company to rapidly spearhead international digital transformation."
— Niki Trigoni, Founder and CTO